Replies to post #12296 on Sunshine Biopharma Inc (SBFM)

[Norton1973]

Hey Bull, you getting a thicker skin. :) Go SBFM.

[vip1999]

:), now all we have to do next is to get rid of the "shock french video" ads on the right then we will be ok.... damn hands are getting tired. LOL!

[reginaliberta]

Bull, the grant were awarded to advanomics , perhaps why we are not seeing the capital trickle to sbfm.
IMHO this will be all merged in one, thus the corporate re domicile.

Advanomics, the parent company of Sunshine Biopharma, has received $510,000 research grant from Canadian Institutes of Health Research (CIHR), to advance the development of Adva-27a, an anticancer drug compound for multidrug resistant tumours.

The grant was awarded jointly to Advanomics and its collaboration partner, Ecole Polytechnique.

Sunshine Biopharma CEO Dr Steve Slilaty said that they are extremely pleased to have garnered the support from CIHR in addition to the support from NSERC and NanoQuebec to develop their novel cancer drug.

"Their commitment will prove invaluable in the advancement of Adva-27a and provides us a strong foundation for clinical trials," Dr Slilaty added.

Adva-27a, which is currently in the IND-enabling development stage, was found to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancers cells.
http://contractresearch.pharmaceutical-business-review.com/news/advanomics-wins-research-grant-for-cancer-drug-candidate-130813